P

Inventor

LONG CHAOFENG

CN17 patents
⚠️ This page may combine multiple inventors who share the name “LONG CHAOFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GUANGDONG RAYNOVENT BIOTECH CO LTD

12 patents
US11535613B2Dec 27, 2022

Crystal form and salt form of pyridoimidazole compound and preparation method therefor

GUANGDONG RAYNOVENT BIOTECH CO LTD6 citations73
US11725009B2Aug 15, 2023

Anti-influenza virus pyrimidine derivative

GUANGDONG RAYNOVENT BIOTECH CO LTD2 citations72
US11136319B2Oct 5, 2021

Anti-influenza virus pyrimidine derivative

GUANGDONG RAYNOVENT BIOTECH CO LTD4 citations72
US10526320B2Jan 7, 2020

Pyrrolidine derivatives as PPAR agonists

GUANGDONG RAYNOVENT BIOTECH CO LTD2 citations72
US10278973B2May 7, 2019

Hydroxyl purine compounds and use thereof

GUANGDONG RAYNOVENT BIOTECH CO LTD2 citations72
US12319692B2Jun 3, 2025

Anti-influenza virus pyrimidine derivatives

GUANGDONG RAYNOVENT BIOTECH CO LTD0 citations62
USRE49128EJul 12, 2022

Hydroxyl purine compounds and applications thereof

GUANGDONG RAYNOVENT BIOTECH CO LTD0 citations62
US10399981B2Sep 3, 2019

Crystal form A of 7-(cyclopropylmethyl)-1-(((cis )-4-hydroxy-4-methylcyclohexyl)methyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione for treating liver diseases

GUANGDONG RAYNOVENT BIOTECH CO LTD1 citations62
US10654808B2May 19, 2020

Tyrosine kinase inhibitor and pharmaceutical composition comprising same

GUANGDONG RAYNOVENT BIOTECH CO LTD1 citations61
US12252487B2Mar 18, 2025

Dominant salt forms of pyrimidine derivatives, and crystal forms thereof

GUANGDONG RAYNOVENT BIOTECH CO LTD0 citations46
US10766862B2Sep 8, 2020

Crystal form and salt form of and preparation method for tyrosine kinase inhibitor

GUANGDONG RAYNOVENT BIOTECH CO LTD0 citations41
US10618898B2Apr 14, 2020

Hydroxyl purine compounds and use thereof

GUANGDONG RAYNOVENT BIOTECH CO LTD0 citations38

GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD

5 patents